Controlling acute episodes of depression

Area of Science:

• Psychiatry
• Clinical Pharmacology
• Neuroscience

Background:

• Acute depressive illness requires effective and well-tolerated treatments.
• Comparative studies are essential to establish the efficacy of new antidepressants against existing therapies and placebo.

Purpose of the Study:

• To evaluate the efficacy and safety of sertraline in treating acute depressive illness.
• To compare sertraline's effectiveness against placebo and amitriptyline.

Main Methods:

• Three double-blind, comparative studies of 6-8 weeks duration were conducted.
• Studies included fixed-dose, forced upward titration, and active-controlled designs.
• Patient populations included moderately to severely depressed individuals, including the elderly, with various diagnoses and anxiety levels.

Main Results:

• Sertraline demonstrated consistent superiority over placebo in treating depression, anxiety, insomnia, and suicidal ideation.
• Sertraline showed equivalent efficacy to amitriptyline in overall therapeutic effect.
• Efficacy was observed in patients with major depression, with or without melancholia, and those with high baseline anxiety.

Conclusions:

• Sertraline is an effective, safe, and well-tolerated treatment option for acute depressive illness.
• Sertraline offers comparable therapeutic benefits to amitriptyline.
• The drug is effective across a spectrum of depressive symptom severity and patient profiles.